How would you manage a patient with a growing central liver metastasis previously treated with SBRT who is ineligible for chemotherapy?   

This is a challenging scenario for which there is no quick/easy solution. My initial assessment would involve obtaining a further understanding of the patient’s performance status/disease course/biology (is this an isolated site of recurrence vs polymetastatic progressive disease), prior SBRT ...